# Bristol-Myers Squibb Company (BMY) — Q2-2011 Earnings Results

**Report date:** 2011-07-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2011

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 1.54%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.56 | N/A | +2.38% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on their product pipeline and operational strategies. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted the continued strength in their pipeline.

> They expressed confidence in upcoming product launches.

> There was an emphasis on maintaining operational efficiency.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, which contributed to a 1.54% increase in stock price. The management's focus on their product pipeline and operational efficiency suggests they are positioning the company for future growth. However, the lack of revenue data and guidance may leave investors seeking more clarity on long-term performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2011_